sameAs
Correction of mucopolysaccharidosis type IIIb fibroblasts by lentiviral vector-mediated gene transferAn uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in miceTIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in miceSUMF1 enhances sulfatase activities in vivo in five sulfatase deficienciesHematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integrationTie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implicationsTargeting the tumor and its microenvironment by a dual-function decoy Met receptorGenetic engineering of hematopoiesis for targeted IFN-α delivery inhibits breast cancer progressionUncovering and dissecting the genotoxicity of self-inactivating lentiviral vectors in vivomiR-511-3p modulates genetic programs of tumor-associated macrophagesCharting a clear path: the ASGCT Standardized Pathways ConferenceGene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector deliveryTargeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional OsteoclastsCorrection of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells.Post-natal cardiomyocytes can generate iPS cells with an enhanced capacity toward cardiomyogenic re-differentation.Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model.Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models.Lentiviral-mediated gene therapy leads to improvement of B-cell functionality in a murine model of Wiskott-Aldrich syndrome.Preclinical safety and efficacy of human CD34(+) cells transduced with lentiviral vector for the treatment of Wiskott-Aldrich syndrome.Quantitative proteomic analysis of lentiviral vectors using 2-DE.Activation of the protein-tyrosine kinase associated with the bombesin receptor complex in small cell lung carcinomasTherapeutic benefit of lentiviral-mediated neonatal intracerebral gene therapy in a mouse model of globoid cell leukodystrophyGene therapy for ADA-SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products.Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration.Tracking differentiating neural progenitors in pluripotent cultures using microRNA-regulated lentiviral vectors.Loss of transcriptional control over endogenous retroelements during reprogramming to pluripotencyLentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy.Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer.Lentiviral vectors, two decades later.Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction.Medicine. A comeback for gene therapy.Minicircle DNA-based gene therapy coupled with immune modulation permits long-term expression of α-L-iduronidase in mice with mucopolysaccharidosis type IHIV-1-derived lentiviral vectors directly activate plasmacytoid dendritic cells, which in turn induce the maturation of myeloid dendritic cells.Large-scale manufacture and characterization of a lentiviral vector produced for clinical ex vivo gene therapy application.Lentiviral vector integration profiles differ in rodent postmitotic tissuesDynamic Activity of miR-125b and miR-93 during Murine Neural Stem Cell Differentiation In Vitro and in the Subventricular Zone Neurogenic Niche.Genomic instability in induced stem cellsFcRgamma activation regulates inflammation-associated squamous carcinogenesis.Forebrain ependymal cells are Notch-dependent and generate neuroblasts and astrocytes after stroke.
P50
Q24534147-ECDEBABA-CAC2-42CC-AC65-F5F541C318D1Q24561588-468D15C0-2BDE-4FD4-AF01-92C372771B6AQ24606406-6A9F4D1D-FEB3-472B-BAD5-A3AD6D31F294Q24683062-F6011D2F-2559-4AAA-9130-901B87A9AD62Q28242708-FBD5BC2A-F886-4104-A8CF-7491A7C9BB42Q28256044-9D94AC7F-7EB0-4ACC-A0A6-6A2DD569580AQ28272715-2481C7D1-9B7F-4E98-88A6-3FF52390E636Q28304978-581CFCD9-1D28-4A21-BD9A-9FF84CCA0E22Q28383769-0ADB941A-8C28-4A18-B776-2D69B23D1F68Q28504706-F012451F-CA7C-4A77-BE02-136DB8F21964Q28655957-5F622F86-56F1-40C3-A5B4-99EC2193D92AQ29014419-3C088854-3975-4DA3-9936-83280CD5A477Q30398603-B9B6D7D1-9CEF-4C92-A4A8-D49804CA99E7Q30501325-5BCB0D5D-40CC-44AB-9AAF-6E3CAFF7ECCCQ30515858-6682922C-FBB3-4A7F-BC29-8C01E71C17F6Q30541387-389B25E4-8097-47C3-A051-DA36E7485D5FQ33383530-C2D1191B-E90F-4A26-8ABD-A97869752420Q33395115-16253938-EB57-462D-850B-4ADAF7956008Q33399943-666DF8C6-D63C-45A1-8280-03981AC633F8Q33488255-E2381B34-7189-4330-B187-CF6179A1696DQ33563141-850A51A3-0F68-4F36-B057-504506CF6E46Q33649318-B5957039-1DF5-4AFA-9A88-BA241D2629C8Q33749021-731DC680-D2F2-4EE5-825B-0643ADBF2B2CQ33943795-15125542-3357-404A-9668-22F9B9F93333Q33952929-5D62C389-70AF-4633-8269-9D7D8EAF4B24Q33994806-37F91C51-D508-42BF-A42A-E971C2D82947Q34356904-0B5C93BF-49B1-421A-83D7-8F04EDBC35ECQ34356914-CFA8D937-D25D-486B-96C6-B048AE7CF5F9Q34516810-C9153745-AA36-4668-99E4-1E998C44900CQ34539903-DD969966-99AB-448E-9C80-C478775D9B00Q34552235-942AC452-DDC7-454B-AD74-7113FDF654A9Q34613525-CEC6881B-55AC-4A2D-85FF-462BAFC9C7A2Q34621690-7316DA4A-5A21-4E1F-B19E-F087BBA96C65Q34623234-D25BFF6D-2D88-4395-8BB3-73949B206AB6Q34624921-BEE6A555-39AA-4DA6-808D-1E6F39A4C450Q34757287-76817B6A-62D1-4D7D-8DDD-289B6A57458CQ34797163-75E5F6CA-19C9-4F31-85A3-F61766B51D0AQ34816201-209474F7-C8D8-4524-A75D-426DC9B8C47AQ34859537-7036B50F-F938-4792-AED3-85978F332737Q34949959-5AEFFFCE-CFC2-468B-A607-4799404413F7
P50
description
Itaalia arst
@et
Italiaans arts
@nl
Italian physician
@en
Italian physician
@en-ca
Italian physician
@en-gb
dochtúir Iodálach
@ga
dokter asal Italia
@id
italienischer Gentherapeut
@de
medic italian
@ro
medico italiano
@it
name
Luigi Naldini
@ast
Luigi Naldini
@ca
Luigi Naldini
@de
Luigi Naldini
@en
Luigi Naldini
@es
Luigi Naldini
@fr
Luigi Naldini
@ga
Luigi Naldini
@it
Luigi Naldini
@lmo
Luigi Naldini
@nl
type
label
Luigi Naldini
@ast
Luigi Naldini
@ca
Luigi Naldini
@de
Luigi Naldini
@en
Luigi Naldini
@es
Luigi Naldini
@fr
Luigi Naldini
@ga
Luigi Naldini
@it
Luigi Naldini
@lmo
Luigi Naldini
@nl
prefLabel
Luigi Naldini
@ast
Luigi Naldini
@ca
Luigi Naldini
@de
Luigi Naldini
@en
Luigi Naldini
@es
Luigi Naldini
@fr
Luigi Naldini
@ga
Luigi Naldini
@it
Luigi Naldini
@lmo
Luigi Naldini
@nl
P106
P1153
7005494915
P166
P21
P2381
P27
P31
P496
0000-0002-7835-527X
P569
1959-01-01T00:00:00Z